Cifarma Científica Farmacêutica LTDA.

cifarma.com.br

Cifarma is a genuinely Brazilian company that was born in Santa Luzia (MG). Founded in 1999 in the era of globalization and with the need to combine technology with humanistic values. In 2002 the company inaugurated its new industrial park installed in an area of ​​100,000 m², in Goiânia (GO), a strategic region for the distribution of its products throughout the country.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

LOVE PHARMAS INVESTMENT IN US BIOTECH OFFERS STRATEGIC INDUSTRY ADVANTAGES AND ENHANCED SHAREHOLDER VALUE

LOVE Pharma | September 09, 2022

news image

Love Pharma Inc. an international mental health and sexual wellness company, remains extremely active in shaping itself into a real competitor in the biotech/pharmaceutical space. The company’s growth and development plan took a major leap forward this week with the announcement that Love Pharma is establishing a “strategic alliance” with Starton Therapeutics a leading clinical-stage biotechnology company in the United States. It’s a relationship that...

Read More

Business Insights

LABCORP PLANS LABORATORY EXPANSION IN JAPAN THROUGH BML COLLABORATION

Labcorp | July 04, 2022

news image

Labcorp a leading global life sciences company, announced that it is enhancing its central laboratory presence and drug development capabilities in Japan through an expansion of CB Trial Laboratory, the central laboratory co-managed by Labcorp Drug Development and BML, a leading Japanese provider of clinical laboratory testing services. Extending their strategic relationship that dates back more than a decade, Labcorp Drug Development and BML will begin work on a new laboratory fa...

Read More

Pharmacy Market

BC PLATFORMS DRIVES DATA ENABLEMENT AND COLLABORATION TO ACCELERATE PRECISION MEDICINE IN ASIA

BC Platforms | June 07, 2022

news image

BC Platforms a leading provider of data and technology platforms for personalized medicine and drug development, will host a key, day-long, Precision Medicine and Data Science Conference in Singapore on 7 June 2022 to discuss how stakeholders can securely collaborate and enable the use of federated data at scale to empower precision medicine, population health, and preventive care initiatives in the region. The event features preeminent local and international experts from healthc...

Read More

Business Insights

SANOFI GLOBAL HEALTH LAUNCHES NONPROFIT IMPACT® BRAND FOR 30 MEDICINES IN LOW-INCOME COUNTRIES

Sanofi | July 05, 2022

news image

Sanofi Global Health announces the launch of Impact®, a new brand of standard of care medicines produced by Sanofi dedicated for nonprofit distribution to at-risk populations in the world’s most impoverished countries. The Impact® brand, which includes insulin, glibenclamide and oxaliplatin amonst others, will enable the secure distribution of 30 Sanofi medicines in 40 lower-income countries. Considered essential by the World Health Organization, the medicines cover ...

Read More
news image

Business Insights

LOVE PHARMAS INVESTMENT IN US BIOTECH OFFERS STRATEGIC INDUSTRY ADVANTAGES AND ENHANCED SHAREHOLDER VALUE

LOVE Pharma | September 09, 2022

Love Pharma Inc. an international mental health and sexual wellness company, remains extremely active in shaping itself into a real competitor in the biotech/pharmaceutical space. The company’s growth and development plan took a major leap forward this week with the announcement that Love Pharma is establishing a “strategic alliance” with Starton Therapeutics a leading clinical-stage biotechnology company in the United States. It’s a relationship that...

Read More
news image

Business Insights

LABCORP PLANS LABORATORY EXPANSION IN JAPAN THROUGH BML COLLABORATION

Labcorp | July 04, 2022

Labcorp a leading global life sciences company, announced that it is enhancing its central laboratory presence and drug development capabilities in Japan through an expansion of CB Trial Laboratory, the central laboratory co-managed by Labcorp Drug Development and BML, a leading Japanese provider of clinical laboratory testing services. Extending their strategic relationship that dates back more than a decade, Labcorp Drug Development and BML will begin work on a new laboratory fa...

Read More
news image

Pharmacy Market

BC PLATFORMS DRIVES DATA ENABLEMENT AND COLLABORATION TO ACCELERATE PRECISION MEDICINE IN ASIA

BC Platforms | June 07, 2022

BC Platforms a leading provider of data and technology platforms for personalized medicine and drug development, will host a key, day-long, Precision Medicine and Data Science Conference in Singapore on 7 June 2022 to discuss how stakeholders can securely collaborate and enable the use of federated data at scale to empower precision medicine, population health, and preventive care initiatives in the region. The event features preeminent local and international experts from healthc...

Read More
news image

Business Insights

SANOFI GLOBAL HEALTH LAUNCHES NONPROFIT IMPACT® BRAND FOR 30 MEDICINES IN LOW-INCOME COUNTRIES

Sanofi | July 05, 2022

Sanofi Global Health announces the launch of Impact®, a new brand of standard of care medicines produced by Sanofi dedicated for nonprofit distribution to at-risk populations in the world’s most impoverished countries. The Impact® brand, which includes insulin, glibenclamide and oxaliplatin amonst others, will enable the secure distribution of 30 Sanofi medicines in 40 lower-income countries. Considered essential by the World Health Organization, the medicines cover ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us